Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Pratley R, Amod A, Hoff ST, Kadowaki T, et al. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial. Lancet 2019 Jun 7. pii: S0140-6736(19)31271.
PMID: 31186120


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016